Merola, Aristide http://orcid.org/0000-0002-5587-726X
Romagnolo, Alberto
Dwivedi, Alok K.
Padovani, Alessandro
Berg, Daniela
Garcia-Ruiz, Pedro J.
Fabbri, Margherita
Artusi, Carlo Alberto
Zibetti, Maurizio
Lopiano, Leonardo
Pilotto, Andrea
Bonacina, Sonia
Morgante, Francesca
Zeuner, Kirsten
Griewing, Christopher
Schaeffer, Eva
Rodriguez-Porcel, Federico
Kauffman, Marcelo
Turcano, Pierpaolo
de Oliveira, Lais M.
Palermo, Giovanni
Shanks, Emily
Del Sorbo, Francesca
Bonvegna, Salvatore
Savica, Rodolfo
Munhoz, Renato P.
Ceravolo, Roberto
Cilia, Roberto
Espay, Alberto J.
Article History
Received: 10 March 2020
Revised: 23 May 2020
Accepted: 26 May 2020
First Online: 2 June 2020
Compliance with ethical standards
:
: Dr Merola is supported by NIH (KL2 TR001426) and has received speaker honoraria from CSL Behring, Abbvie, and Cynapsus Therapeutics. He has received grant support from Lundbeck. Dr Romagnolo has received grant support and speaker honoraria from AbbVie, speaker honoraria from Chiesi Farmaceutici and travel grants from Lusofarmaco, Chiesi Farmaceutici, Medtronic, and UCB Pharma. Dr. Dwivedi is supported as a co-investigator by the NIH (1R01HL125016-01), (1 R21 HL143030-01) and (1R21 AI133207) grants and as a collaborator in NIH R21 AI118228 grant. He has been also serving as a statistician in CPRIT grants (PP180003, PP170068, PP170004, PP140164, 140211, PP110156, PP150031, and PP130083), CCTST K12 (consultant) award, Coldwell (co-investigator) and TMF (co-investigator). Dr. Dwivedi is a director of Biostatistics & Epidemiology Consulting Lab at the TTUHSC EP. Dr. Padovani has received grant support from Ministry of Health (MINSAL) and Ministry of Education, Research and University (MIUR), from CARIPLO Foundation; personal compensation as a consultant/scientific advisory board member for Avanir, Lundbeck, Eli-Lilly, Neuraxpharma, Biogen, GE Health. Dr. Berg reports grants from Janssen Pharmaceutica, grants from Damp foundation, grants from German Parkinson’s Disease Association (dPV), grants from BMWi, grants from BMBF, grants from Parkinson Fonds Deutschland GmbH, grants and speaker’s honoraria from and consultancies for UCB Pharma GmbH, grants from Novartis Pharma GmbH, grants and speaker’s honoraria from and consultancies for Lundbeck, speaker’s honoraria from and consultancies for BIAL, grants from the EU, speaker’s honoraria from and consultancies for Biogen, and speaker’s honoraria from AbbVie, Zambon and Desitin. Dr. Garcia-Ruiz has received research support from Allergan and UCB, personal compensation as a consultant/scientific advisory board from Italfarmaco, Britannia, Bial, Zambon, and speaker’s honoraria from Italfarmaco, UCB, Zambon, Allergan and Abbvie. Dr. Fabbri has no financial conflicts to disclose. Dr. Artusi has received travel grants from Zambon and Abbvie. Dr. Zibetti has received honoraria from Medtronic, Zambon Pharma and AbbVie. Dr. Lopiano has received honoraria for lecturing and travel grants from Medtronic, UCB Pharma, and AbbVie. Dr. Pilotto has received speaker honoraria from BioMarin Pharmaceutical, Chiesi Pharmaceuticals, Nutricia Pharmaceuticals, UCB Pharma and Zambon Pharmaceuticals. He received grants from the Italian Ministry of Health, Zambon Italia, Vitaflo Germany. Dr. Bonacina has no financial conflicts to disclose. Dr. Morgante has received speaking honoraria from Medtronic, Zambon, Chiesi, Abbvie, Merz, Bial; personal compensation as a consultant/scientific advisory board member from Merz, Abbvie, Bial, Medtronic. Dr. Zeuner has received research support from an intramural grant from the Christian-Albrechts-University of Kiel, from the Benign Essential Blepharospasm Research Foundation and with an unrestricted grant from Ipsen. She has received lecture fees from Allergan, Merz, AbbVie and Bayer outside the submitted work. She has served as a consultant and received fees from Merz and Ipsen. Dr. Griewin has no financial conflicts to disclose. Dr. Schaeffer has received intramural research funding from the University of Kiel and speaker’s honoraria from Bayer Vital GmbH and Novartis. Dr. Rodriguez-Porcel has no financial conflicts to disclose. Dr. Kauffman is an employee of the CONICET. He has received grant support from Ministry of Science and Technology of Argentina and Ministry of Health of Buenos Aires. He has received honoraria payments for educational activities from Janssen Pharmaceuticals and Bago Pharmaceuticals. Dr. Turcano has no financial conflicts to disclose. Dr. de Oliveira has no financial conflicts to disclose. Dr. Palermo has no financial conflicts to disclose. Ms. Shanks has no financial conflicts to disclose. Dr. Del Sorbo has no financial conflicts to disclose. Dr. Bonvegna has no financial conflicts to disclose. Dr. Savica has received research support from the National Institute on Aging, the National Institute of Neurological Disorders and Stroke, the Mayo Clinic Small Grants Program National Center for Advancing Translational Sciences (NCATS), and unrestricted grant from ACADIA Pharmaceuticals, INC. Dr. Munhoz has no financial conflicts to disclose. Dr. Ceravolo has received fees for speech by Abbvie, General Electric, Zambon, UCB, Lusofarmaco. Dr. Cilia has has received speaking honoraria from Zambon, UCB, Bial; personal compensation as a consultant from Roche. Dr. Espay has received grant support from the NIH, Great Lakes Neurotechnologies and the Michael J Fox Foundation; personal compensation as a consultant/scientific advisory board member for Abbvie, TEVA, Impax, Acadia, Acorda, Intrance, Cynapsus/Sunovion, Lundbeck, and USWorldMeds; publishing royalties from Lippincott Williams & Wilkins, Cambridge University Press, and Springer; and honoraria from Abbvie, UCB, USWorldMeds, Lundbeck, Acadia, the American Academy of Neurology, and the Movement Disorders Society.
: The study received IRB/ethics committee approval at all participating centers and was conducted in accordance with the Good Clinical Practice and the International Conference on Harmonization guidelines and any applicable national and local regulations. The authors declare that they acted in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki.